BioArctic Future Growth
Future criteria checks 6/6
BioArctic is forecast to grow earnings and revenue by 48.2% and 37.6% per annum respectively. EPS is expected to grow by 48.2% per annum. Return on equity is forecast to be 55.5% in 3 years.
Key information
48.2%
Earnings growth rate
48.2%
EPS growth rate
Biotechs earnings growth | 39.0% |
Revenue growth rate | 37.6% |
Future return on equity | 55.5% |
Analyst coverage | Good |
Last updated | 22 Apr 2024 |
Recent future growth updates
Recent updates
Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)
Apr 13News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat
Feb 19News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat
Feb 03Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues
Dec 23With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case
Nov 12BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be
Jul 21Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results
Jul 15New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)
Jul 07Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade
May 06Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth
Mar 13Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher
Nov 30We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn
Sep 16We're Interested To See How BioArctic (STO:BIOA B) Uses Its Cash Hoard To Grow
Apr 04We Think BioArctic (STO:BIOA B) Can Easily Afford To Drive Business Growth
Dec 05BioArctic AB (publ) (STO:BIOA B) Shares Could Be 42% Below Their Intrinsic Value Estimate
Sep 15BioArctic (STO:BIOA B) Is In A Strong Position To Grow Its Business
Aug 23Is BioArctic AB (publ) (STO:BIOA B) Trading At A 41% Discount?
Jun 03Shareholders Will Probably Not Have Any Issues With BioArctic AB (publ)'s (STO:BIOA B) CEO Compensation
Apr 29Is BioArctic's (STO:BIOA B) Share Price Gain Of 291% Well Earned?
Mar 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,233 | 1,240 | 1,069 | 1,250 | 4 |
12/31/2025 | 1,010 | 454 | 483 | 499 | 6 |
12/31/2024 | 502 | 17 | 130 | 137 | 6 |
12/31/2023 | 616 | 229 | 302 | 310 | N/A |
9/30/2023 | 611 | 259 | 111 | 124 | N/A |
6/30/2023 | 620 | 270 | 283 | 289 | N/A |
3/31/2023 | 622 | 327 | 294 | 307 | N/A |
12/31/2022 | 229 | -11 | -44 | -32 | N/A |
9/30/2022 | 232 | 28 | -15 | -13 | N/A |
6/30/2022 | 18 | -147 | -170 | -159 | N/A |
3/31/2022 | 21 | -135 | -147 | -143 | N/A |
12/31/2021 | 26 | -120 | -145 | -140 | N/A |
9/30/2021 | 30 | -114 | -138 | -128 | N/A |
6/30/2021 | 37 | -97 | -114 | -103 | N/A |
3/31/2021 | 34 | -101 | -106 | -93 | N/A |
12/31/2020 | 65 | -69 | -105 | -92 | N/A |
9/30/2020 | 84 | -72 | -125 | -120 | N/A |
6/30/2020 | 93 | -60 | -163 | -160 | N/A |
3/31/2020 | 252 | 78 | -46 | -43 | N/A |
12/31/2019 | 283 | 88 | 324 | 327 | N/A |
9/30/2019 | 779 | 441 | 286 | 292 | N/A |
6/30/2019 | 852 | 475 | 305 | 310 | N/A |
3/31/2019 | 729 | 380 | 171 | 176 | N/A |
12/31/2018 | 722 | 382 | -204 | -200 | N/A |
9/30/2018 | 257 | 58 | -161 | -157 | N/A |
6/30/2018 | 197 | 32 | -152 | -149 | N/A |
3/31/2018 | 194 | 29 | -143 | -139 | N/A |
12/31/2017 | 157 | 15 | -139 | -135 | N/A |
9/30/2017 | 193 | 78 | N/A | 616 | N/A |
6/30/2017 | 160 | 71 | N/A | 630 | N/A |
3/31/2017 | 127 | 64 | N/A | 647 | N/A |
12/31/2016 | 106 | 58 | N/A | 675 | N/A |
12/31/2015 | 42 | 4 | N/A | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIOA B's forecast earnings growth (48.2% per year) is above the savings rate (0.9%).
Earnings vs Market: BIOA B's earnings (48.2% per year) are forecast to grow faster than the Swedish market (13.5% per year).
High Growth Earnings: BIOA B's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BIOA B's revenue (37.6% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: BIOA B's revenue (37.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BIOA B's Return on Equity is forecast to be very high in 3 years time (55.5%).